Related Experiment Video
Updated: Jul 1, 2026

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Caffeine Consumption and Rhinologic Symptom Severity
Duncan G J Green1, Steven X Wang2, Michael S DeBakey2
1Department of Otorhinolaryngology, Ochsner Health, New Orleans, Los Angeles, USA.
Abstract:
Caffeine is the most widely consumed habit-forming drug in the world. A relationship has been proposed between caffeine consumption and rhinologic symptoms. To determine whether the potential deleterious effects of caffeine withdrawal are outweighed by the rhinologic symptom benefits, our group conducted a prospective study of patients presenting with rhinologic complaints at local clinics. Rhinologic symptom severity was assessed using the SNOT-22 and the frequency and quantity of daily caffeine consumption was assessed by questionnaire. A total of 226 participants completed the study. No correlation was found between caffeine consumption and total SNOT-22 (P > .05), rhinologic SNOT-22 subscale (P > .05), or tertiles of low, medium, and high caffeine consumers (P = .18). This suggests that caffeine consumption does not have an appreciable effect on rhinologic symptoms.
Related Concept Videos
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in various...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Asthma III: Clinical Manifestations
Asthma-III: Symptoms and Complications
Classification of Asthma
